A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

Clinical trial NCT06512883 · RECRUITING

Trial details

NCT number: NCT06512883
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Granulomatosis With Polyangiitis (EGPA)Hypereosinophilia Syndrome (HES)

Start date: 2025-04-17
Primary completion: 2028-02-20
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.